{
  "id": 10484898,
  "title": "DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System",
  "url": "https://urgent.news/2026/09/28/diagnos-advances-regulatory-strategy-with-us-fda-submission-for-cara",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T15:57:53.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/diagnos-advances-regulatory-strategy-with-us-fda-submission-for-cara-system"
  },
  "original_language": "en",
  "account": null,
  "summary": "BROSSARD, Quebec, Sept. 28, 2026 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that it has submitted a Section 513(g) Request for Information to the U.S. Food and […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}